aCenter for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil
bThe Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia
cDepartment of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia
dLaboratorio de Imunofarmacologia, Departamento de Bioquimica e Imunologia, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
eDepartment of Cellular Biology, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, São Paulo, Brazil
*Corresponding author. Address: Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Av. Bandeirantes 3900, CEP 14049-900, Ribeirão Preto, São Paulo, Brazil. Tel.: +55 16 3602-0199; fax: +55 16 3633-2301. E-mail address: [email protected] (T.M. Chuna).
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.painjournalonline.com).
F.V. Santa-Cecília and D.W. Ferreira are co-first authors.
